Retreatment in locally recurrent nasopharyngeal carcinoma:Current status and perspectives  

作　　者：Sharon Shuxian Poh Yoke Lim Soong Kiattisa Sommat Chwee Ming Lim Kam Weng Fong Terence WK Tan Melvin LK Chua Fu Qiang Wang Jing Hu Joseph TS Wee 

机构地区：[1]Division of Radiation Oncology,National Cancer Centre Singapore,Singapore 169610 [2]Oncology Academic Clinical Programme,Duke-NUS Graduate Medical School,Singapore 169857 [3]Department of Otorhinolaryngology-Head and Neck Surgery,Singapore General Hospital,Singapore 169608 [4]Surgery Academic Clinical Programme,Duke-NUS Graduate Medical School,Singapore 169857

出　　处：《Cancer Communications》2021年第5期361-370,共10页癌症通讯（英文）

摘　　要：1 Background Nasopharyngeal carcinoma(NPC)arises from the epithelial cells that cover and line the nasopharynx.While it is considered a rare cancer globally,it is commonly observed in South China and a few other ethnically distinct racial groups.Due to its propensity to spread early through the submucosal tissue and the highly infiltrative nature of this disease,NPC spreads easily through areas of lesser resistance within the pharyngobasilar fascia with a tendency for neural infiltration[1-3].

关 键 词：Nasopharyngeal Carcinoma Radiation Oncology Head and Neck Tumor 

分 类 号：R73[医药卫生—肿瘤]